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Abstract
Background: In vivo studies were conducted to quantify the effectiveness of low-level direct electric current for different
amounts of electrical charge and the survival rate in fibrosarcoma Sa-37 and Ehrlich tumors, also the effect of direct electric in
Ehrlich tumor was evaluate through the measurements of tumor volume and the peritumoral and tumoral findings.
Methods: BALB/c male mice, 7–8 week old and 20–22 g weight were used. Ehrlich and fibrosarcoma Sa-37 cell lines, growing
in BALB/c mice. Solid and subcutaneous Ehrlich and fibrosarcoma Sa-37 tumors, located dorsolaterally in animals, were initiated
by the inoculation of 5 × 106 and 1 × 105 viable tumor cells, respectively. For each type of tumor four groups (one control group
and three treated groups) consisting of 10 mice randomly divided were formed. When the tumors reached approximately 0.5
cm3, four platinum electrodes were inserted into their bases. The electric charge delivered to the tumors was varied in the range
of 5.5 to 110 C/cm3 for a constant time of 45 minutes. An additional experiment was performed in BALB/c male mice bearing
Ehrlich tumor to examine from a histolological point of view the effects of direct electric current. A control group and a treated
group with 77 C/cm3 (27.0 C in 0.35 cm3) and 10 mA for 45 min were formed. In this experiment when the tumor volumes
reached 0.35 cm3, two anodes and two cathodes were inserted into the base perpendicular to the tumor long axis.
Results: Significant tumor growth delay and survival rate were achieved after electrotherapy and both were dependent on
direct electric current intensity, being more marked in fibrosarcoma Sa-37 tumor. Complete regressions for fibrosarcoma Sa-
37 and Ehrlich tumors were observed for electrical charges of 80 and 92 C/cm3, respectively.
Histopathological and peritumoral findings in Ehrlich tumor revealed in the treated group marked tumor necrosis, vascular
congestion, peritumoral neutrophil infiltration, an acute inflammatory response, and a moderate peritumoral monocyte
infiltration. The morphologic pattern of necrotic cell mass after direct electric current treatment is the coagulative necrosis.
These findings were not observed in any of the untreated tumors.
Conclusion: The data presented indicate that electrotherapy with low-level DEC is feasible and effective in the treatment of
the Ehrlich and fibrosarcoma Sa-37 tumors. Our results demonstrate that the sensitivity of these tumors to direct electric
current and survival rates of the mice depended on both the amount of electrical charge and the type of tumor. Also the
complete regression of each type of tumor is obtained for a threshold amount of electrical charge.
Published: 26 November 2004
BMC Cancer 2004, 4:87 doi:10.1186/1471-2407-4-87
Received: 15 July 2004
Accepted: 26 November 2004
This article is available from: http://www.biomedcentral.com/1471-2407/4/87
© 2004 Ciria et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
Page 2 of 10
(page number not for citation purposes)
Background
The use of electric current in the treatment of malignant
tumors has been known since the beginning of the 19th
century. Several investigators have reported encouraging
results from experimental low-level direct current therapy
(DEC) in different types of tumor [1-3]. These studies
have shown that DEC has an antitumor effect in different
animal tumor models and in clinic; however, it has not yet
been universally accepted.
The dose-response relationships obtained in these studies
indicate that the DEC effectiveness depends on both the
type of tumor and therapeutic scheme (amount of electri-
cal charge and electrode array). Lack of guidance has
become an obstacle to introduce the electrochemical
treatment (EChT) in the clinic oncology. This is due to the
lack of standardization of the EChT method regarding
DEC doses and electrode array. Ren et al. [4] studied the
influence of the dose and electrode spacing in the breast
cancer and concluded that an increase of the dose lead to
an increase in both the necrosis percentage and increased
survival rate. However, they did not find significant spac-
ing effect on the tumor necrosis percentage. On the other
hand, Chou et al. [5] revealed that the number of elec-
trodes depends on the tumor size and that the electrodes
inserted at the base perpendicular to the tumor long axis
increased the antitumor effectiveness respect to other elec-
trode configurations used.
In spite of these results, the efficacy of DEC treatment has
been controversial since an optimum electrode array and
a threshold amount of electrical charge for each type of
tumor have not been established. We believe that the pro-
cedure to determine the amount of electrical charge for
each type of tumor is completely destroyed is more feasi-
ble to implement than that for the optimum electrode
array, which involves several variables, such as polarity,
number, and orientation of the electrodes. The knowledge
of the optimum values of these parameters may lead to
maximize the antitumor effectiveness of DEC and mini-
mize their adverse effects in the organism. This allows the
establishment of a therapeutic procedure for the tumor
treatment in animals and in clinical oncology.
The aim of this study is to test the hypothesis that the
responses of the tumors treated with DEC is dependent on
dose. Ehrlich and fibrosarcoma Sa-37 tumors were used.
The survival rates of the mice bearing of these two types of
tumor were determined. The antitumor effects of DEC
were also evaluated through the peritumoral and tumoral
findings in Ehrlich tumor.
Methods
Animals
The experiment was run in accordance with Good Labora-
tory Practice rules and animals protection laws. The exper-
iment was approved by the ethical committee of Oriente
University, which follows the guideline from the Cuban
Animal Ethical Committee. BALB/c male mice, 7–8 week
old and 20–22 g weight were used. They were supplied
from the National Center for Production of Laboratory
Animals (CENPALAB), Havana City, Cuba, and were kept
in standard laboratory conditions with water and food ad
libitum. Animals were healthy (without signs of fungal or
other infections) and were maintained in plastic cages
inside a room at a constant temperature of 23 ± 2°C and
relative humidity of 65 %, and a natural day-night cycle.
During therapy the animals were firmly fixed on wooden
boards, so all treatments were performed in the absence of
anesthesia. All treated animals showed uneasy and quick
breathing during fixation.
Tumor cell lines
Ehrlich and fibrosarcoma Sa-37 cell lines, growing in
BALB/c mice, were received from the Center for Molecular
Immunology, Havana City, Cuba. Both cell lines are being
maintained in the Cell Culture Collection of the Depart-
ment of Pathologic Anatomy, Hospital "Conrado
Benítez", Santiago de Cuba, Cuba.
The Ehrlich and fibrosarcoma Sa-37 ascitic tumor cell sus-
pensions, transplanted to the BALB/c mouse, were pre-
pared from the ascitic forms of the tumors. Ehrlich solid
and subcutaneous tumors, located dorsolaterally in ani-
mals, were initiated by the inoculation of 5 × 106 viable
tumor cells in 0.2 ml of 0.9 % NaCl, while fibrosarcoma
Sa-37 solid and subcutaneous tumors located dorsolater-
ally in animals, were initiated by the inoculation of 1 ×
105 viable tumor cells in 0.2 ml of 0.9 % NaCl. For both
tumors, the viability of the cells was determined by
Trypan blue dye exclusion test and it was over 95 %. Cell
count was made using an hematocytometer.
Tumor growth was followed by measuring three perpen-
dicular tumor diameters (a, b and c, where a > b > c) with
a vernier caliper. The tumor volume was estimated using
the equation  . The mean tumor volume with
the corresponding standard deviation of three determina-
tions was calculated in each experimental group. Mice
with non-palpable tumor at day 60 after the treatment
were designated as cured.
Tumor doubling time (DT, in days) was determined for
each individual tumor as the time needed to double the
initial tumor volume. For each experimental group the
mean DT and its standard deviation were calculated.
V
abc
=π
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Histopathological study of the Ehrlich tumor
The histologic cuts from each tumor were made according
to the largest diameter. They were fixed in a 10 % formol
solution and processed by the paraffin method.
Hematoxylin and eosin stained slides were used to evalu-
ate the presence of necrosis. Hematoxylin and eosin
stained slides were examined under an Olympus light
microscope. The extent of necrosis was defined as the per-
centage of necrotic region compared with the whole area
of the tumor section.
The peritumoral alterations were evaluated as none (-),
slight (+), moderate (++) and severe (+++).
Electrochemical treatment
To supply electrochemical treatment, a high stability and
low noise DEC source was built at the National Center for
Applied Electromagnetism (CNEA). The electrode config-
uration consisted of a multi-electrode array formed by two
anodes and two cathodes inserted into the base perpen-
dicular to the tumor long axis keeping about 3 mm dis-
tance between them. Cathode and anode were connected
in alternate sequence. This multi-electrodes array was pro-
posed taking into account the results reported by Chou et
al. [5]. All electrodes were cleaned and sterilized in alco-
hol prior to use. Platinum electrodes of 0.7 mm diameter
and 20 mm long were used. After the electrodes were
inserted, they were connected to the DEC source.
In order to find the thresholds of the electrical charge for
which Ehrlich and fibrosarcoma Sa-37 tumors are com-
pletely destroyed, different amounts of electrical charge in
the range of 5.5 to 110 C/cm3 were used. From this range
of electrical charge three values were chosen to show the
DEC effectiveness in both types of tumors. When the
tumors reached approximately 0.5 cm3 in BALB/c mice, a
single shot electrotherapy was supplied (zero day). For
each type of tumor four groups consisting of 10 mice each
randomly divided were formed. For Ehrlich tumor the
groups formed were: control group (CG1), treated group
with electrical charge of 36 C/cm3 (18.0 C in 0.5 cm3) and
6.7 mA for 45 min (TG1-1), treated group with 63 C/cm3
(31.5 C in 0.5 cm3) and 11.7 mA for 45 min (TG1-2), and
treated group with 92 C/cm3 (46.0 C in 0.5 cm3) and 17
mA for 45 min (TG1-3). For fibrosarcoma Sa-37 tumor
the groups formed were: control group (CG2), treated
group with 36 C/cm3 (18 C in 0.5 cm3) and 6.7 mA for 45
min (TG2-1), treated group with 63 C/cm3 (31.5 C in 0.5
cm3) and 11.7 mA for 45 min (TG2-2), and treated group
with 80 C/cm3 (40.0 C in 0.5 cm3) and 14.8 mA for 45
min (TG2-3).
The dose of 105 C/cm3 (52.5 C in 0.5 cm3) and 19.4 mA
for 45 min was supplied to 10 mice (5 mice bearing Ehr-
lich tumor and 5 mice bearing fibrosarcoma Sa-37
tumor). Also the dose of 110 C/cm3 (55 C in 0.5 cm3) and
20.3 mA for 45 min was supplied to 10 mice (5 mice bear-
ing Ehrlich tumor and 5 mice bearing fibrosarcoma Sa-37
tumor). These doses were used to evaluate the therapeutic
and adverse effects of the DEC above 100 C/cm3. For each
type of tumor was formed a control group of 10 mice.
In order to examine from the histolological point of view
the effects of direct electric current in Ehrlich tumor two
experimental groups were formed: a control group (CG-A)
and a treated group with 77 C/cm3 (27.0 C in 0.35 cm3)
and 10 mA for 45 min (TG-A). This treated group was
divided in three subgroups TG1-A, TG2-A and TG3-A to
show the tumor and peritumoral findings at 1, 2 and 4
days after DEC treatment. Each experimental group was
formed by 6 mice. When the Ehrlich tumor volumes
reached 0.35 cm3, two anodes and two cathodes were
inserted into the base perpendicular to the tumor long
axis and a single shot electrotherapy was supplied (zero
day).
In all experiments, before treatment the DEC was
increased gradually step by step for two minutes until the
desired intensity. During treatment it was constant and
continually monitored. The voltage was also continually
monitored. It varied, in accordance with the change of tis-
sue resistance during the current application, between 5
and 25 V. The total electrical charge was calculated in real
time. After a single application of the intended dose, the
treatment was stopped. In this case, the current was
decreased step by step for two minutes until its intensity
was 0 mA. During electrotherapy, mice were firmly
restrained, without obvious discomfort; therefore no
anesthesia was necessary.
In the control groups, four electrodes were placed into the
base perpendicular to the tumor long axis without apply-
ing any direct current (0 mA). The animals of this group
were firmly fixed but without DEC and showed uneasy
and quick breathing during their fixation.
Survival rates of the mice bearing both types of the tumors
were determined for each experimental group. The sur-
vival rate (in %) was defined as the ratio between the
number of live animals and the total number of animals,
multiplied by 100 %. Survival checks mortality were made
daily.
Histopathological study of the tumor
The histologic cuts from each tumor were made according
to the largest diameter. They were fixed in a 10 % formal
solution and processed by the paraffin method.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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Hematoxylin and eosin staining was used. Each cut was
divided into four microscopic fields in order to calculate
the necrosis percentage through panoramic lens. This per-
centage was calculated as the ratio between the necrosis
area and the tumor total area, multiplied by 100 %.
Statistical criteria
The nonparametric statistical criterion of one-tailed Wil-
coxon-Mann-Whitney rank sum was used to compare vol-
umes between the treated groups with DEC and their
respective control groups. Survival curves for the three dif-
ferent mice treatment groups for each tumor type were
estimated by using the Kaplan-Meier product limit esti-
mator [6].
McNemar's statistical criterion was used for comparing
the main histopathological findings in peritumoral zones
in animals from CG-A and TG-A. P values of less than 0.05
were considered significant. The mean value and its mean
standard error were reported for each experimental group.
Results
As it is shown in Table 1 and Figure 1, Ehrlich tumors in
DEC-treated mice were significantly inhibited as com-
pared with tumors of untreated mice (P < 0.02). This
tumor growth inhibition following DEC treatment was
observed in every individual mouse. Also there are signif-
icant differences between the treated groups being more
evident for TG1-3 (P < 0.05). Similar effect of DEC treat-
ment was observed in fibrosarcoma Sa-37 bearing mice
(Table 1 and Fig. 2). In these mice DEC treatment also
resulted in significant inhibition of tumor growth (P <
0.02). For this type of tumor also were observed signifi-
cant differences between the treated groups being more
evident for TG2-3 (P < 0.05).
The results shown in this study revealed that the sensitiv-
ity of the Ehrlich and fibrosarcoma Sa-37 tumors was dose
dependent. The sensitivity to DEC of both types of tumors
increased with the increase of the amount of electrical
charge (Table 1 and Figs. 1 and 2). These results also made
evident that fibrosarcoma Sa-37 tumor were more sensi-
tive to DEC than Ehrlich tumor under the same amount of
electrical charge (TG1-1 compared with TG2-1 and TG1-2
compared with TG2-2). For these doses there were
significant differences (P < 0.05). It was also observed on
Ehrlich tumor for doses of 36 and 63 C/cm3 that the
tumors partially regressed for 2 and 4 days, respectively.
Table 1: Mean doubling time
Ehrlich Tumor Fibrosarcoma Sa-37 tumor
CG1 TG1-1 TG1-2 TG1-3 CG2 TG2-1 TG2-2 TG2-3
DT1 2.4 ± 0.3 6.8 ± 0.7 16.9 ± 2.4 ∞3 1.6 ± 0.2 11.2 ± 1.3 23.6 ± 3.8 ∞3
- 2.9 7.1 ∞3 - 7.0 14.9 ∞3
1 DT (in days) is the double time of the tumors. Data are means ± standard deviation of tumors.
2 DTTG/CG is a variable that characterizes the increase of DT in each treated group. (DTTG) in respect to its control group (DTCG) for both types of 
tumors.
3 The symbol ∞ means infinite tumor doubling time (see Discussion).
DT
DT
GT
GC
2
Effect of DEC on the growth curve of Ehrlich tumor Figure 1
Effect of DEC on the growth curve of Ehrlich tumor. 
Data are means ± mean standard error (vertical bars). The 
experimental groups formed for the Ehrlich tumor were con-
trol group, CG1 (-■ -); treated group with 36 C/cm3, TG1-1 
(-● -); treated group with 63 C/cm3, TG1-2 (-▲ -); treated 
group with 92 C/cm3, TG1-3 (-▼ -). Each experimental group 
is formed by 10 mice.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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For these same doses the fibrosarcoma Sa-37 tumor
reached their respective partial regressions for 4 and 5
days. Both eventually outgrew again.
The complete regression of the Ehrlich tumor was
observed 25 days after treatment with 92 C/cm3 (Table 1
and Fig. 1); however, for the fibrosarcoma Sa-37 tumor it
was observed 15 days post-treatment with 80 C/cm3
(Table 1 and Fig. 2). After 60 days post-treatment the
tumors were non palpable in TG1-3 and TG2-3. For these
doses there were no significant differences (P > 0.05) in
the growth of these two types of tumor after treatment;
however, there were significant differences in the time for
which each type of tumor was completely destroyed (P <
0.05).
In the case of the untreated tumors, fibrosarcoma Sa-37
tumor showed a quicker growth than that of the Ehrlich
tumor. Also, the DT of fibrosarcoma Sa-37 was 0.7 times
smaller than that of the Ehrlich tumor (Table 1).
The overall survival curves of the mice bearing Ehrlich and
fibrosarcoma Sa-37 tumors are shown in figures 3 and 4,
respectively. These figures show that for both types of
tumors the survival rate of the mice treated with DEC was
significantly greater when compared with that of their
Effect of DEC on the growth curve of fibrosarcoma Sa-37  tumor Figure 2
Effect of DEC on the growth curve of fibrosarcoma 
Sa-37 tumor. Data are means ± mean standard error (ver-
tical bars). The experimental groups formed for the fibrosar-
coma Sa-37 tumor were control group, CG2 (-■ -); treated 
group with 36 C/cm3, TG2-1 (-● -); treated group with 63 C/
cm3, TG2-2 (-▲ -); treated group with 80 C/cm3, TG2-3 (-▼ -
). Each experimental group is formed by 10 mice.
Survival rates in BALB/c mice bearing Ehrlich tumor after  electrochemical treatment Figure 3
Survival rates in BALB/c mice bearing Ehrlich tumor 
after electrochemical treatment. Data are means ± 
mean standard error (vertical bars). The experimental 
groups formed for the Ehrlich tumor were control group, 
CG1 (-■ -); treated group with 36 C/cm3, TG1-1 (-● -); 
treated group with 63 C/cm3, TG1-2 (-▲ -); treated group 
with 92 C/cm3, TG1-3 (-▼ -). Each experimental group is 
formed by 10 mice.
Survival rates in BALB/c mice bearing fibrosarcoma Sa-37  tumor after electrochemical treatment Figure 4
Survival rates in BALB/c mice bearing fibrosarcoma 
Sa-37 tumor after electrochemical treatment. Data 
are means ± mean standard error (vertical bars). The experi-
mental groups formed for the fibrosarcoma Sa-37 tumor 
were control group, CG2 (-■ -); treated group with 36 C/
cm3, TG2-1 (-● -); treated group with 63 C/cm3, TG2-2 (-▲ -
); treated group with 80 C/cm3, TG2-3 (-▼ -). Each experi-
mental group is formed by 10 mice.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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respective untreated mice (P < 0.001). In this figure it was
also observed that the cure rates were 80 % (8/10) for
Ehrlich tumor (TG1-3) and 90 % (9/10) for fibrosarcoma
Sa-37 tumor (TG2-3). Significant differences between the
survival rates of the mice treated with different amounts of
electrical charge (P < 0.05) were also found, being more
marked for TG1-3 and TG2-3 for Ehrlich and
fibrosarcoma Sa-37 tumors, respectively. For the dose of
36 C/cm3 there were no significant differences between
both types of tumor (P > 0.05); however, for the other
doses there were significant differences (P < 0.05).
The cured mice were sacrificed at 100 days post-treatment.
Before sacrifice, the animals were active and in good phys-
ical condition with adequate body weight. They had good
posture and coats of hair. After sacrifice, the histopatho-
logical findings in each of these mice showed complete
disappearance of the tumor and evidence of healing. In
the treated mice a very little necrotic tissue remained
within a fibrous scar. Serology and histological finding of
the organs did reveal neither abnormalities nor metastases
(results not shown).
The death of a mouse 1-day after DEC treatment was
observed in TG1-3. The histological findings revealed
damages in the lungs due to hemorrhage and a small cir-
cular necrosis. Metastases were not observed in this
mouse. It was also observed the death of a mouse 25 days
post-treatment in TG1-3 and 50 days in TG2-3 due to the
cannibalism shown by the mice, probably because of the
blood present in the tumors after DEC treatment. All the
mice died for amounts of electrical charge above 100 C/
cm3, during the first 24 hours after DEC treatment. The
histological findings showed both severe alterations in
liver and kidney and an increase in the weight of these
organs. Metastases were not observed in any of these mice.
The histopathological findings revealed that in the Ehrlich
untreated tumors (CG-A) the necrotic area was mainly
Central necrosis area in an Ehrlich untreated tumor (+) Figure 5
Central necrosis area in an Ehrlich untreated tumor (+). HE. 
× 32.
Necrosis area in the Ehrlich treated tumor (+) 2 days after  DEC treatment Figure 6
Necrosis area in the Ehrlich treated tumor (+) 2 days after 
DEC treatment. HE. × 32.
Necrosis area in the Ehrlich treated tumor (+) 4 days after  DEC treatment Figure 7
Necrosis area in the Ehrlich treated tumor (+) 4 days after 
DEC treatment. HE. × 32.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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central and it constituted approximately from 20 % of the
tumor total area (Fig. 5). However, in tumors treated with
DEC, a wide necrotic area was observed. The tumor necro-
sis percentages of treated groups at 1, 2 and 4 days after
treatment were approximately 2.7, 3.9 (Fig. 6) and 4.7
(Fig. 7) times higher than that of the CG-A, respectively.
These differences were significant (P < 0.02). Also there
were significant differences between the necrosis percent-
ages of treated tumors at 1, 2 and 4 days (P < 0.02).
There was a lack of well defined necrosis zones surround-
ing the electrodes. The morphologic pattern of the
necrotic cell mass observed is the coagulative necrosis.
The dead tissue becomes both swollen and firm in
consistency. Preservation of the basic profile of the coagu-
lated cancerous cell and nuclear karyolysis were also
observed. The lysed erythrocytes was also observed. This
type of necrosis was accompanied by accumulation of
neutrophil polymorphonuclear leucocytes.
Lymphocytes (L) and plasmatic cells, named CP, were
observed in all the tumors in CG-A and TG-A but there
were no significant differences (Table 2, Fig. 8).
Neutrophil infiltration (N) and vascular congestion,
named CV, were observed in all animals from the TG-A
(Figs. 9 and 10). The intensity grades of these peritumoral
findings were severe; however, the intensity grade of the
monocyte infiltration (M) was slight to moderate in this
TG-A. Edema and acute inflammatory response were
observed 1, 2 and 4 days after treatment (Figs. 9 and 10).
These peritumoral findings were not present in any of the
animals from the CG-A (Table 2). There were significant
differences (P = 0.008) between the peritumoral findings
of the CG-A and TG-A.
Lymphoplasmocytic infiltrate in both untreated and DEC  treated tumors: plasmatic cells (CP) and lymphocytes (L) Figure 8
Lymphoplasmocytic infiltrate in both untreated and DEC 
treated tumors: plasmatic cells (CP) and lymphocytes (L). HE. 
× 400.
Peritumoral findings of treated tumors at 1 day after DEC  treatment: leucocytes neutrophil infiltration (N), monocytes  (M) and lymphocytes (L) Figure 9
Peritumoral findings of treated tumors at 1 day after DEC 
treatment: leucocytes neutrophil infiltration (N), monocytes 
(M) and lymphocytes (L). HE. × 400.
Pattern of acute inflammatory response observed during 1, 2  and 4 days after treatment Figure 10
Pattern of acute inflammatory response observed during 1, 2 
and 4 days after treatment: vascular congestion (CV) and 
neutrophils (N). HE. × 100.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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In this experiment no mouse died from intercurrent dis-
ease during or after the treatment. Before sacrifice, the ani-
mals were active and in good physical condition with
adequate body weight. They had good posture and coats
of hair.
Discussion
The results of this study demonstrated that DEC has a
marked antitumor effect because a single-shot
electrotherapy delivered via four platinum electrodes
inserted into the base of the fibrosarcoma Sa-37 and Ehr-
lich murine tumors significantly retarded their growths
when compared with their respective control groups. The
fact that tumor regression increases with the increase of
the amount of electrical charge may be explained because
the induced necrosis by DEC into the tumor depends
directly on its intensity, a matter that is in agreement with
the results of Robertson et al. [7]. In an additional experi-
ment was corroborated that the decrease of each treated
tumor volume is due to the higher necrosis percentage
induced into the tumor by DEC action. The histopatho-
logical findings made to mice 100 days post-treatment
may suggest that an increase of the dose bring about an
increase of the percentage of the tumor necrosis and the
necrotic overlap. Also these findings confirm that the
results of the pathology study were consistent with the
survival study.
We believe that the necrosis is the predominant mecha-
nism of cell death, by the cellular tumefaction (or cellular
swelling), cell rupture, breakdown of organelles and acute
inflammatory response observed during the first 4 days
post-treatment in all treated tumors, result that agrees
with that previously reported by Dodd et al. [8] and
Holandino et al. [9]. Von Euler et al. [10] demonstrated
that the appearance of the necrosis depends on the polar-
ity of the electrode. The findings of necrosis observed by
these researchers around anode and cathode electrodes
were also observed in all treated tumors (coagulative
necrosis, extravasation of blood cells, nuclear karyolysis
and edema), fact that was explained because both
electrodes were inserted into the tumors. On the other
hand, Von Euler [11] observed both apoptosis and necro-
sis around the anode but only necrosis around cathode.
The necrosis may be due to the ischemia observed in all
tumors treated with DEC, which could lead to an irrevers-
ible cell injury of the tumor cells and therefore to cellular
death. This fact could be related with other experimental
findings found after DEC treatment, such as: degradation
of phospholipids, lost of high energy phosphate and
increase of the intracellular calcium [7], membrane dam-
age [5], ionic imbalance [2,12], mitochondrial alterations
[9] and ischemia/reperfusion injury [13].
Table 2: Peritumoral pathological findings The number of the mice in each experimental group is specified by n. CGA is the control 
group and TG1-A, TG2-A and TG3-A are the experimental subgroups of the group treated with 77 C/cm3at 1, 2 and 4 days after DEC 
treatment, respectively. Mc Nemar Test shows statistically significant differences in peritumoral findings at 1, 2 and 4 days.
Alterations found Experimental Groups Number of mice (% of the total) in different degrees of 
alterationb
- + ++ +++
Lymphoplasmocytic infiltrate: Lymphocytes (L) 
and plasmatic cells (CP)
CGA (n = 6) 0 (0.0) 0 (0.0) 6 (100.0) 0 (0.0)
TGA-1 day (n = 6) 0 (0.0) 0 (0.0) 6 (100.0) 0 (0.0)
TGA-2 days (n = 6) 0 (0.0) 0 (0.0) 6 (100.0) 0 (0.0)
TGA-4 days (n = 6) 0 (0.0) 0 (0.0) 6 (100.0) 0 (0.0)
Neutrophilic infiltrate (N) CGA (n = 6) 6 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
TGA-1 day(n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
TGA-2 days (n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
TGA-4 days (n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
Monocytic infiltrate (M) CGA (n = 6) 6 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
TGA-1 day (n = 6) 0 (0.0) 6 (100.0)a 0 (0.0) 0 (0.0)
TGA-2 days (n = 6) 0 (0.0) 0 (0.0) 6 (100.0)a 0 (0.0)
TGA-4 days (n = 6) 0 (0.0) 0 (0.0) 6 (100.0)a 0 (0.0)
Vascular congestion (CV) CGA (n = 6) 6 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
TGA-1 day (n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
TGA-2 days (n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
TGA-4 days (n = 6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (100.0)a
a P = 0.008.
b Note: The signs " -, +, ++ and +++ ", represent: none, slight, moderate and severe intensity grades of alterations found, respectively.BMC Cancer 2004, 4:87 http://www.biomedcentral.com/1471-2407/4/87
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The prolonged acute inflammation observed during 4
days after DEC treatment may be explained by the persist-
ent leukocyte infiltrate also observed in the peritumoral
findings. This persistent leukocyte infiltrate (essential fea-
ture of the inflammatory response) becomes a harmful
agent because during the chemotaxis they amplify the
effects of the initial inflammatory stimulus through the
liberation of potent mediators (enzymes, chemical
mediators and toxic radical of oxygen) that lead to both
endothelial and tissue damages. This leukocyte infiltrate
may also activate the immune system [14]. In all these
processes the reactive oxygen species have been shown to
have an important role. In addition to these species are
essential elements in the emergence of an inflammatory
process [14,15]. Therefore we speculate that the oxidative
burst may be the immediate cause of cell death in both
tumors, although not investigated in this study.
These facts and the high necrosis percentages shown in
this study may lead to the complete destruction of the
solid tumor treated with DEC. The complete disappear-
ance of the Ehrlich and fibrosarcoma Sa-37 tumors
achieved for 92 and 80 C/cm3, respectively, may suggest
that each tumor model has its threshold of electric charge
from which it is completely destroyed. This threshold
depends on the electric nature of the tumor and their
physiological characteristics (stage, volume and his-
togenic characteristics). This fact explains the cure of the
mice and why the tumors do not duplicate their initial
volumes during the observation time (infinite DT, repre-
sented in Table 1 by ∞ symbol).
The experimental data revealed that the fibrosarcoma Sa-
37 showed the higher sensitivity and curability to DEC
than Ehrlich tumor and that both tumor response and
survival rate of mice were DEC dependent. However, in
the untreated tumors Fibrosarcoma Sa-37 showed a DT
shorter than that of the Ehrlich tumor. This fact indicates
the higher agressiveness of Fibrosarcoma Sa-37.
The mortality observed in all animals treated with
amounts of electrical charge above 100 C/cm3 could be
explained by the severe damages induced by DEC in kid-
ney and liver. Griffin et al. [12] explained this result by the
induced serum electrolyte imbalance resulting from a
metabolic load due to the breakdown products of the
tumors.
The hemorrhage observed in the lungs of the mouse death
1 day after DEC treatment in TG1-3 may be explained by
the vascular rupture and/or perforation of blood vessels
due to a mechanic effect by the insertion of an electrode.
The small circular necrosis also observed in this organ's
mouse may be consequence of the cytotoxic action of
DEC.
The uneasy and quick breathing observed in both control
and treated groups, during the fixation of the mice did not
have any influence in the results obtained in this study.
Conclusions
The data presented indicate that electrotherapy with low-
level DEC is feasible and effective in the treatment of the
Ehrlich and fibrosarcoma Sa-37 tumors. Our results
demonstrate that the sensitivity of these tumors to direct
electric current and survival rates of the mice depended on
both the amount of electrical charge and the type of
tumor. Also the complete regression of each type of tumor
is obtained for a threshold amount of electrical charge.
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